StonvexLoading…
StonvexStonvexStonvexCore line items from TKR's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $1.23B | $4.58B | $3.47B | $2.31B |
Operating Income | $168.60M | $540.60M | $431.20M | $291.80M |
Net Income | $98.20M | $288.40M | $226.10M | $156.80M |
EPS (Diluted) | $1.40 | $4.11 | $3.22 | $2.23 |
Total Assets | $6.88B | $6.68B | $6.80B | $6.81B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $344.70M | $364.40M | $449.10M | $419.30M |
Free Cash Flow OCF − CapEx | $500.00K | $406.10M | $265.40M | $101.60M |
Shares Outstanding | 70.20M | 70.23M | 70.23M | 70.28M |